Risk factors for recurrent infection in the surgical treatment of infected massive endoprostheses implanted for musculoskeletal tumours.

MLA

Azamgarhi, Tariq, et al. “Risk Factors for Recurrent Infection in the Surgical Treatment of Infected Massive Endoprostheses Implanted for Musculoskeletal Tumours.” Journal of Orthopaedic Surgery & Research, vol. 18, no. 1, Jan. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s13018-022-03446-1.

APA

Azamgarhi, T., Warren, S., Aston, W., Pollock, R., & Gerrand, C. (2023). Risk factors for recurrent infection in the surgical treatment of infected massive endoprostheses implanted for musculoskeletal tumours. Journal of Orthopaedic Surgery & Research, 18(1), 1–12. https://doi.org/10.1186/s13018-022-03446-1

Chicago

Azamgarhi, Tariq, Simon Warren, Will Aston, Rob Pollock, and Craig Gerrand. 2023. “Risk Factors for Recurrent Infection in the Surgical Treatment of Infected Massive Endoprostheses Implanted for Musculoskeletal Tumours.” Journal of Orthopaedic Surgery & Research 18 (1): 1–12. doi:10.1186/s13018-022-03446-1.